New: Top 90 Surrogacy Agencies in USA

June 13, 2025 09:22 AM PDT | By EIN Presswire
 New: Top 90 Surrogacy Agencies in USA
Image source: EIN Presswire

NEW YORK, NY, UNITED STATES, June 13, 2025 /EINPresswire.com/ -- Surrogacy4All Unveils 2025 Rankings of Top U.S. Surrogacy Agencies: Elevating Transparency, Safety & Success

Surrogacy4All today released its much‑anticipated 2025 Surrogacy Agency Rankings, spotlighting 90 leading U.S. agencies out of over 300 USA based agencies through a data‑driven analysis focused on clinical success, match time, cost transparency, regulatory compliance, and client satisfaction.

“Choosing a surrogacy agency is more than a business decision—it’s a leap of faith toward your dream of parenthood,” said Dr. Veera Saghar, lead author and reproductive medicine expert. “Our rigorous rankings help prospective parents cut through marketing fluff and focus on what truly matters: safety, results, speed, and trust.”

Top Highlights from the 2025 Report:

Tier 1 Agencies:

Agencies meeting the highest standards—New York State licensed, FDA registered, and physician‑owned or former surrogate/operator led—include:

Conceive Abilities (NYS licensed, FDA registered, 4.1‑star Google score, founded 1996)

Family Inceptions International LLC (licensed, registered, 4.9‑star, founded 2008)

Happy Beginnings LLC (licensed, registered, 4.9‑star, founded 2005)

Surrogacy4All.com (licensed, registered, 4.9‑star, physician‑owned, fastest match times)

Tier 2 Agencies

FDA‑registered agencies without New York licensing include:

CCRM Fertility
Coast to Coast Surrogacy
fertile.com/ RSMC

Key Metrics & Trends

Match Time: Tier 1 agencies averaged 0–1 month to secure a surrogate, compared to 6–10 months industry‑wide

Cost Transparency: Surrogacy journeys now average $160K–$180K, ranging from $110K to $350K.

Agency Leadership: 39 agencies hold NYS licenses; only 7 are FDA‑registered. Physician‑ or surrogate‑led teams dominate Tier 1 and Tier 2, underscoring a shift toward medically and ethically grounded leadership

Click on this link to access the Ranks: https://www.surrogacy4all.com/2025-best-surrogacy-agencies-usa/

About the Rankings

Developed through a comprehensive review of over 90 U.S. agencies, the methodology assessed Clinical outcomes and IVF/live‐birth success rates, Surrogate placement speed, Licensing (NYS) and federal (FDA) oversight, Online reputation via Google reviews (avg. ~4.5/5), Operational longevity (46 agencies with 10+ years in business), Fee transparency, medical oversight, and legal safeguards

Agencies are stratified into four tiers to guide intended parents toward compliance, trust, and care.

Why We Created Tier Rankings

In surrogacy, licensing and/or FDA registration matters.

Without it, there’s no way to know if an agency is real or just a website out to steal your money.

That’s why New York State began licensing surrogacy agencies — and why we highlight licensed, physician-led, FDA-registered programs in Tier 1,Tier 2 and Tier 3.

✅ Safety. ✅ Transparency. ✅ Accountability.

“After years of failed attempts, Surrogacy4All matched us to find the most incredible surrogate. Today, we’re parents to a beautiful baby girl. The team walked with us every step of the way.”
— Emily & David, New York

About Surrogacy4All

Surrogacy4All is a leading informational platform committed to helping intended parents navigate the journey toward building their families. The organization compiles independent rankings, educational content, and expert insights into transracial, LGBTQ+, and international surrogacy. For inclusion in future rankings—or to submit your agency data—contact [email protected].


For media inquiries or interviews with Dr. Saghar, please email [email protected].

Dee Gulati
Surrogacy4All.com
+1 917-601-3863
[email protected]
Visit us on social media:
LinkedIn
Instagram
Facebook
X
Other

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations, and video (Content) is a service of Kalkine Media LLC., having Delaware File No. 4697309 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


Sponsored Articles


Investing Ideas

Previous Next